lead plaintiff

BlackRock TCP Capital Corp. faces class action lawsuit alleging materially false statements on valuations and NAV. Shareholders can register as lead plaintiff by April 6, 2026.

Lufax Holding Ltd ($LU) faces class action lawsuit alleging materially false statements, weak internal controls, and misstated financials from April 2023 to January 2025.

Rosen Law Firm filed securities class action against $FBRT, alleging false statements on business prospects and dividend sustainability. Lead plaintiff deadline set for April 27, 2026.

PayPal faces securities fraud lawsuit over false growth claims. Stock dropped 20.3% after surprise CEO change and missed earnings. Investors have until April 20, 2026, for lead plaintiff status.

Trip.com investors can file claims by May 11, 2026, in lawsuit alleging the company concealed Chinese antitrust investigation and monopolistic practice risks.

Grocery Outlet faces securities fraud lawsuit after missing March 2026 guidance and announcing 36 store closures with $110M impairment charge, triggering 27.9% stock collapse.

Class action lawsuit filed against Kyndryl for alleged false financial statements and internal control failures during August 2024-February 2026 period.

Rosen Law Firm files class action lawsuit against Gartner, alleging false financial disclosures. Investors have until May 18, 2026 to join action.

Law firm pursues class action against $FBRT for alleged misstatements after Q4 earnings miss. Stock fell 14.2% on weak guidance.

ODDITY Tech ($ODD) faces class action lawsuit alleging securities fraud over undisclosed ad partner algorithm changes that triggered 30% Q1 revenue decline.

Robbins Geller files class action against monday.com ($MNDY) alleging false revenue projections. Stock plunged 21% after company withdrew 2027 guidance.

Gartner faces securities fraud suit after 48% stock decline linked to reduced guidance. Investors can apply as lead plaintiffs through Kahn Swick & Foti, LLC.

Ultragenyx ($RARE) faces class action lawsuit over failed setrusumab Phase 3 trials, with stock down 42%. Investors have until April 6, 2026 to seek lead plaintiff status.

Rosen Law Firm filed securities class action against $LU alleging false statements on internal controls and financials. Investors have until May 20, 2026 to claim lead plaintiff status.

Navan investors face April 2026 deadline to join class action over allegedly misleading IPO disclosures. Stock has fallen 63% after undisclosed 39% expense increase announcement.

Class action lawsuit filed against $LU alleging securities fraud, false statements, and weak internal controls from April 2023 through January 2025.

Rosen Law Firm recruits investors for securities class action against REGENXBIO over alleged RGX-111 gene therapy misstatements. Lead plaintiff deadline: April 14, 2026.

Snowflake faces securities fraud suit after 18% stock drop on corrective disclosures regarding consumption patterns and $10B revenue target claims.

$DRVN plunged nearly 40% after disclosing accounting errors and control weaknesses requiring multi-year restatement. Securities fraud lawsuit filed with May 8 deadline.

Class action lawsuit filed against $HTGC alleging overstated due diligence and misrepresented portfolio valuations in loan origination and deal sourcing processes.